Home › Prostate Cancer › NCT07875192

Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting

A Single-center Study of Robotic Prostatectomy Surgeries Performed Using the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in an Ambulatory Surgical Center Setting

Who can join

Ages 18 and older · Men

Inclusion Criteria:

* Subjects (male) ≥ 18 years old
* Subject has been indicated for a radical prostatectomy surgical procedure
* Subject is able to be treated with robotic surgery
* Subject is willing to participate and consents to participate, as documented by signed Institutional Review Board (IRB) approved informed consent form

Exclusion Criteria:

* Contraindicated for treatment with the Hugo™ RAS System in accordance with the commercial Instructions for Use and local regulations
* Subject is participating in another clinical investigation at the time of enrollment or has planned participation in another clinical investigation at any time during this study that may influence the results of this study

About the study

A Single-center Study of Robotic Prostatectomy Surgeries Performed using the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in an Ambulatory Surgical Center Setting

Sponsor: Central Ohio Urology Group · Participants: 100 · Started: Oct 27, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07875192

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.